BNP PARIBAS ARBITRAGE/CALL/DIASORIN/95/0.1/20.06.24 | Market Closed - Borsa Italiana 21:04:59 06/06/2024 BST | ||
| 0.675 EUR | -3.30% |
|
| Current month | +9.61% | ||
| 1 month | +68.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
DIASORIN S.P.A.
Latest news about DIASORIN S.P.A.
More news
| Date | Price | Change |
|---|---|---|
| 06/06/24 | 0.673 | -3.58% |
| 05/06/24 | 0.698 | +13.50% |
| 04/06/24 | 0.615 | +4.59% |
| 03/06/24 | 0.588 | -4.23% |
| 31/05/24 | 0.614 | -14.72% |
Real-time Borsa Italiana
Last update June 06, 2024 at 09:04 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | DIASORIN S.P.A. |
| Issuer | 
BNP Paribas
|
| P20BE1 | |
| ISIN | NLBNPIT20BE1 |
| Date issued | 06/03/2024 |
| Strike | 95 € |
| Maturity | 20/06/2024 (14 Days) |
| Parity | 10 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.992 € |
|---|---|
| Lowest since issue | 0.1105 € |
| Spread | 0.226 € |
| Spread % | 28.61% |
Company Profile
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc.
At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Sector
-
Consensus: DiaSorin S.p.A.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
100.7
EUR
Average target price
101.7
EUR
Spread / Average Target
+0.95%
- Stock Market
- Warrants
- P20BE1 Warrant